Tweet
Hello, how much is MiSeq (include service. warranty)? I saw Illumina has MiniSeq online. Has anyone used it before? How much is MiniSeq?
Ben
Ben
-
-
MiniSeq was announced at ~$50K that probably includes 1 yr warranty/service. You will have to contact a sales person to get exact pricing. -
Thanks, do you know how much is MiSeq roughly. For individual research lab (not sequencing lab), which is better?Originally posted by GenoMax View PostComment
-
Don't know for sure but somewhere between $100-125K would be my guess.
Depends on how much sequencing you will doing and what yield you need per sample. If you can afford it, MiSeq may be best, since it is truly a workhorse. You can potentially sell spare capacity to others locally to recoup some of your investment.Last edited by GenoMax; 08-18-2017, 09:35 AM.Comment
-
I'm not that familiar with either but in my mind I just thought of the MiniSeq as a cheaper version of the MiSeq, with the downside that you can't do long (for Illumina) reads. They both do 25M clusters, do a run in a day, but the MiSeq supports 2x300 reads and the MiniSeq does 2x150.Originally posted by GenoMax View PostProviding nextRAD genotyping and PacBio sequencing services. http://snpsaurus.comComment
-
Plus MiniSeq uses 2-color chemistry. Something to keep in mind.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has... -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment